Condition
Low-risk Papillary Thyroid Cancer
Total Trials
1
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
Treatment Research
2 treatments under study, led by Total Thyroidectomy Tt
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
100.0%
1 terminated out of 1 trials
Success Rate
0.0%
-86.6% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
1 of 0 completed with results
Key Signals
1 with results0
Data Visualizations
Phase Distribution
1Total
Phase 2 (1)
Trial Status
Terminated1
Clinical Trials (1)
Research Network
Common Treatments
- Total Thyroidectomy Tt1
- Prophylactic Central Neck Lymph Node Dissection Pcnd1
Active Sponsors
- National Cancer Institute (NCI)1
Top Investigators
National Cancer Institute (NCI)
Related Conditions
- Endocrine Malignancy1
- Thyroid Cancer1